Cerebral rituximab uptake in multiple sclerosis: A 89Zr-immunoPET pilot study

被引：18

作者：

Hagens, Marloes H. J. ^{[1
,2
]}

Killestein, Joep ^{[1
,2
]}

Yaqub, Maqsood M. ^{[3
]}

van Dongen, Guus A. M. S. ^{[3
]}

Lammertsma, Adriaan A. ^{[3
]}

Barkhof, Frederik ^{[2
,3
]}

van Berckel, Bart N. M. ^{[2
,3
]}

机构：

[1] Vrije Univ Amsterdam Med Ctr, Dept Neurol, De Boelelaan 1117, NL-1081 HV Amsterdam, Netherlands

[2] Vrije Univ Amsterdam Med Ctr, MS Ctr Amsterdam, Amsterdam, Netherlands

[3] Vrije Univ Amsterdam Med Ctr, Dept Radiol & Nucl Med, Amsterdam, Netherlands

来源：

MULTIPLE SCLEROSIS JOURNAL | 2018年 / 24卷 / 04期

关键词：

Multiple sclerosis; rituximab; monoclonal antibodies; B-lymphocytes; positron emission tomography; magnetic resonance imaging; IMMUNO-PET;

D O I：

10.1177/1352458517704507

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Previous studies have demonstrated that the chimeric monoclonal antibody rituximab significantly reduces clinical and radiological disease activity in relapsing-remitting multiple sclerosis as early as 4weeks after the first administration. The exact mechanisms leading to this rapid effect have not yet been clarified. The aim of this positron emission tomography study was to assess central nervous system penetration as a possible explanation, using zirconium-89-labelled rituximab. No evidence was found for cerebral penetration of [Zr-89]rituximab.

引用

页码：543 / 545

页数：3

共 50 条

[31] Lipoic acid in multiple sclerosis: a pilot study
Yadav, V
Marracci, G
Lovera, J
Woodward, W
Bogardus, K
Marquardt, W
Shinto, L
Morris, C
Bourdette, D
MULTIPLE SCLEROSIS JOURNAL, 2005, 11 (02) : 159 - 165
[32] Arterial Compliance in Multiple Sclerosis: A Pilot Study
Fjeldstad, Cecilie
Frederiksen, Christine
Fjeldstad, Anette S.
Bemben, Michael
Pardo, Gabriel
ANGIOLOGY, 2010, 61 (01) : 31 - 36
[33] Pilot study: Fatigue, sleep and multiple sclerosis
Beran, RG
Ainley, LA
Holland, GJ
NEUROLOGY, 2005, 64 (06) : A21 - A21
[34] Testosterone treatment in multiple sclerosis - A pilot study
Sicotte, Nancy L.
Giesser, Barbara S.
Tandon, Vinita
Klutch, Ricki
Steiner, Barbara
Drain, Ann E.
Shattuck, David W.
Hull, Laura
Wang, He-Jing
Elashoff, Robert M.
Swerdloff, Ronald S.
Voskuhl, Rhonda R.
ARCHIVES OF NEUROLOGY, 2007, 64 (05) : 683 - 688
[35] Rituximab in multiple sclerosis A retrospective observational study on safety and efficacy
Salzer, Jonatan
Svenningsson, Rasmus
Alping, Peter
Novakova, Lenka
Bjorck, Anna
Fink, Katharina
Islam-Jakobsson, Protik
Malmestrm, Clas
Axelsson, Markus
Vagberg, Mattias
Sundstrom, Peter
Lycke, Jan
Piehl, Fredrik
Svenningsson, Anders
NEUROLOGY, 2016, 87 (20) : 2074 - 2081
[36] Safety and efficacy of rituximab in multiple sclerosis: A retrospective observational study
Zeineddine, Maya
Ayyoubi, Nabil
Nicolas, Johny
Khoury, Samia
Yamout, Bassem
MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (02) : NP21 - NP22
[37] A retrospective observational study of rituximab in multiple sclerosis patients in Cyprus
Leonidou, E.
Pantzaris, M.
Kleopa, K.
Kyriakides, T.
Loizidou, M.
Christou, Y. P.
MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 912 - 913
[38] Rituximab in multiple sclerosis, a long term safety and efficacy study
Islam-Jakobsson, P.
Alping, P.
Salzer, J.
Bjorck, A.
Fink, K.
Frisell, T.
Piehl, F.
Svenningsson, A.
MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 574 - 574
[39] Safety and Efficacy of Rituximab in Multiple Sclerosis: A Retrospective Observational Study
Yamout, Bassem I.
El-Ayoubi, Nabil K.
Nicolas, Johny
El Kouzi, Yehya
Khoury, Samia J.
Zeineddine, Maya M.
JOURNAL OF IMMUNOLOGY RESEARCH, 2018, 2018
[40] Evaluation of safety of rituximab in patients with multiple sclerosis: A retrograde study
Majdinasab, Nastaran
Sadrian, Mitra
Kashipazha, Davood
Moradi, Maryam
CURRENT JOURNAL OF NEUROLOGY, 2020, 19 (03): : 103 - 106

← 1 2 3 4 5 →